Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study.

Genestreti G, Giovannini N, Frizziero M, Maglie M, Sanna S, Cingarlini S, Molino AM, Piciucchi S, Cetto GL, Santo A.

J Chemother. 2011 Aug;23(4):232-7.

PMID:
21803702
2.

End of life in cancer patients: drugs or words?

Aitini E, Adami F, Cetto GL.

Ann Oncol. 2010 May;21(5):914-5. doi: 10.1093/annonc/mdq218. No abstract available.

PMID:
20423917
3.

Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy.

Riolfi M, Ferla R, Del Valle L, Piña-Oviedo S, Scolaro L, Micciolo R, Guidi M, Terrasi M, Cetto GL, Surmacz E.

Brain Pathol. 2010 Mar;20(2):481-9. doi: 10.1111/j.1750-3639.2009.00323.x. Epub 2009 Aug 6.

4.

Bone metastases from primary cardiac sarcoma: case report.

Strina C, Zannoni M, Parolin V, Cetto GL, Zuliani S.

Tumori. 2009 Mar-Apr;95(2):251-3.

PMID:
19579876
5.

Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis.

Bonomi M, Nortilli R, Molino A, Sava T, Santo A, Caldara A, Cetto GL.

Med Oncol. 2010 Jun;27(2):224-9. doi: 10.1007/s12032-009-9195-y. Epub 2009 Mar 28.

PMID:
19330470
6.

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study.

Celio L, Sternberg CN, Labianca R, La Torre I, Amoroso V, Barone C, Pinotti G, Cascinu S, Di Costanzo F, Cetto GL, Bajetta E.

Ann Oncol. 2009 Jun;20(6):1062-7. doi: 10.1093/annonc/mdn766. Epub 2009 Feb 13.

PMID:
19218305
7.

Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.

Fiorio E, Mercanti A, Terrasi M, Micciolo R, Remo A, Auriemma A, Molino A, Parolin V, Di Stefano B, Bonetti F, Giordano A, Cetto GL, Surmacz E.

BMC Cancer. 2008 Oct 22;8:305. doi: 10.1186/1471-2407-8-305.

8.

Clinical stage I seminoma.

Consoli F, Sava T, Cetto GL.

Tumori. 2008 Jan-Feb;94(1):1-6. Review.

PMID:
18468326
9.

Bone Marrow Micrometastases in Breast Cancer Patients: A Long-Term Follow-up Study.

Molino A, Giovannini M, Micciolo R, Auriemma A, Fiorio E, Santo A, Cetto GL.

Clin Med Oncol. 2008;2:487-90. Epub 2008 Sep 4.

10.

Adjuvant treatment in the management of testis-confined germ cell tumours after orchidectomy.

Sava T, Consoli F, Santo A, Cetto GL.

BJU Int. 2008 Jan;101(2):155-9. Epub 2007 Jul 23. Review.

11.

Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients.

Santo A, Genestreti G, Terzi A, Azzoni P, Sava T, Manno P, Molino A, Pattaro C, Micciolo R, Cetto GL.

Lung Cancer. 2006 Sep;53(3):355-60. Epub 2006 Jul 11.

PMID:
16837100
12.

Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC).

Santo A, Genestreti G, Sava T, Manno P, Terzi A, Molino AM, Cetto GL.

Ann Oncol. 2006 May;17 Suppl 5:v55-61. Review. No abstract available.

PMID:
16807464
13.

[Non-small cell lung cancer (NSCLC): the evolution of neo-adjuvant chemotherapy in the last 15 years].

Santo A, Genestreti G, Fiorio E, Terzi A, Lonardoni A, Calabrò F, Campaldini B, Colaluca P, Molino A, Cetto GL.

Recenti Prog Med. 2006 Apr;97(4):211-8. Review. Italian.

PMID:
16729492
14.

A good death for cancer patients: still a dream?

Aitini E, Cetto GL.

Ann Oncol. 2006 May;17(5):733-4. Epub 2006 Mar 24. No abstract available.

PMID:
16565211
15.

Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer.

Molino A, Giovannini M, Auriemma A, Fiorio E, Mercanti A, Mandarà M, Caldara A, Micciolo R, Pavarana M, Cetto GL.

Crit Rev Oncol Hematol. 2006 Sep;59(3):226-33. Epub 2006 Mar 13.

PMID:
16533603
16.

Chemotherapy for metastatic melanoma.

Mandarà M, Nortilli R, Sava T, Cetto GL.

Expert Rev Anticancer Ther. 2006 Jan;6(1):121-30. Review.

PMID:
16375649
17.

Cytofluorimetric evaluation of DNA ploidy in lung cancer: a bronchoscopic study.

Oliani C, Barana D, Cazzadori A, Zanolin E, Santo A, Pasini F, Padovani M, Mazzini G, Cetto GL.

Int J Biol Markers. 2005 Apr-Jun;20(2):87-92.

PMID:
16011038
18.

High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy.

Pasini F, de Manzoni G, Pedrazzani C, Grandinetti A, Durante E, Gabbani M, Tomezzoli A, Griso C, Guglielmi A, Pelosi G, Maluta S, Cetto GL, Cordiano C.

Ann Oncol. 2005 Jul;16(7):1133-9. Epub 2005 Jun 9.

PMID:
15946974
19.

New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.

Sava T, Basso U, Porcaro A, Cetto GL.

Expert Rev Anticancer Ther. 2005 Feb;5(1):53-62. Review.

PMID:
15757438
20.

Gamma knife radiosurgery in brain metastases from testicular tumors.

Nicolato A, Ria A, Foroni R, Manno P, Alessandrini F, Sava T, Lupidi F, Leone P, Maluta S, Cetto GL, Gerosa M.

Med Oncol. 2005;22(1):45-56.

PMID:
15750196
21.

Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study.

Oliani C, Padovani M, Manno P, Barana D, Falconi M, Bassi C, Cavallini G, Pederzoli P, Cetto GL.

Anticancer Res. 2004 May-Jun;24(3b):2107-12.

22.

Correlations between family history and cancer characteristics in 2256 breast cancer patients.

Molino A, Giovannini M, Pedersini R, Frisinghelli M, Micciolo R, Mandarà M, Pavarana M, Cetto GL.

Br J Cancer. 2004 Jul 5;91(1):96-8.

23.

Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.

Piga A, Nortilli R, Cetto GL, Cardarelli N, Fedeli SL, Fiorentini G, D'Aprile M, Giorgi F, Parziale AP, Contu A, Montironi R, Gesuita R, Carle F, Cellerino R.

Br J Cancer. 2004 May 17;90(10):1898-904.

24.

Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC.

Barana D, van der Klift H, Wijnen J, Longa ED, Radice P, Cetto GL, Fodde R, Oliani C.

Am J Med Genet A. 2004 Mar 15;125A(3):318-9. No abstract available.

PMID:
14994245
25.

Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer.

Cappuzzo F, Mazzoni F, Gennari A, Donati S, Salvadori B, Orlandini C, Cetto GL, Molino A, Galligioni E, Mansutti M, Tumolo S, Lucentini A, Valduga F, Bartolini S, Crinò L, Conte PF.

Br J Cancer. 2004 Jan 12;90(1):31-5.

26.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W, Villa E, Verusio C, Cetto GL, Santo A, De Pangher V, Artioli F, Cacciani GC, Parodi G, Soresi F, Ghi MG, Morabito A, Biason R, Giusto M, Mosconi P, Chiarion Sileni V; GSTVP (Gruppo di Studio Tumori Polmonari del Veneto).

Lung Cancer. 2004 Jan;43(1):83-91.

PMID:
14698542
27.

Prognostic significance of laminin, laminin receptor, and bone marrow micrometastases in breast cancer patients: are these markers of aggressive behavior and metastatic potential?

Molino A, Pedersini R, Micciolo R, Frisinghelli M, Giovannini M, Pavarana M, Santo A, Colato C, Piubello Q, Cetto GL.

Appl Immunohistochem Mol Morphol. 2003 Dec;11(4):311-8.

PMID:
14663356
28.

Relationship between the thymidine labeling and Ki-67 proliferative indices in 126 breast cancer patients.

Molino A, Pedersini R, Micciolo R, Frisinghelli M, Giovannini M, Pavarana M, Nortilli R, Santo A, Manno P, Padovani M, Piubello Q, Cetto GL.

Appl Immunohistochem Mol Morphol. 2002 Dec;10(4):304-9.

PMID:
12607597
29.

Economic aspects of high-dose chemotherapy: a clinician's perspective review.

Cetto GL, Molino A.

Crit Rev Oncol Hematol. 2002 Feb;41(2):251-67. Review.

PMID:
11856600
30.

A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis.

Santo A, Pedersini R, Pasini F, Terzi A, Pari F, Cartei G, Sibau A, Molino A, Maiorino A, Panza N, Oletti MV, Maluta S, Calabrò F, Cetto GL.

Lung Cancer. 2001 Dec;34 Suppl 4:S15-20.

PMID:
11742697
31.

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

Chiarion Sileni V, Nortilli R, Aversa SM, Paccagnella A, Medici M, Corti L, Favaretto AG, Cetto GL, Monfardini S.

Melanoma Res. 2001 Apr;11(2):189-96.

PMID:
11333130
32.

Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma.

Bonetti A, Zaninelli M, Leone R, Franceschi T, Fraccon AP, Pasini F, Sabbioni R, Cetto GL, Sich D, Brienza S, Howell SB.

Ann Oncol. 2001 Feb;12(2):187-91.

PMID:
11300322
33.

The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer.

Conte P, Salvadori B, Donati S, Gennari A, Cetto GL, Molino A, Crino L, Mazzoni F, Galligioni E, Mansutti M.

Oncology (Williston Park). 2001 Feb;15(2 Suppl 3):41-3.

34.

Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers.

Molino A, Pavarana M, Micciolo R, Nortilli R, Pedersini R, Manno P, Bozzi P, Bonetti F, Piubello Q, Cetto GL.

Ann Oncol. 2000 May;11(5):581-6.

PMID:
10907952
35.

Bone marrow micrometastases in breast cancer patients.

Molino A, Pelosi G, Micciolo R, Turazza M, Nortilli R, Pavanel F, Cetto GL.

Breast Cancer Res Treat. 1999 Nov;58(2):123-30.

PMID:
10674876
36.

Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients.

Pelosi G, Pasini F, Ottensmeier C, Pavanel F, Bresaola E, Bonetti A, Fraggetta F, Terzi A, Iannucci A, Cetto GL.

Br J Cancer. 1999 Dec;81(7):1213-21.

37.

Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II study.

Lippe P, Tummarello D, Monterubbianesi MC, Silva RR, Giuliodori L, Mari D, Santo A, Pasini F, Cetto GL, Rossi D, Porfiri E, Cascinu S, Cellerino R.

Ann Oncol. 1999 Feb;10(2):217-21.

PMID:
10093692
38.

bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer.

Bonetti A, Zaninelli M, Leone R, Cetto GL, Pelosi G, Biolo S, Menghi A, Manfrin E, Bonetti F, Piubello Q.

Clin Cancer Res. 1998 Oct;4(10):2331-6.

39.

Does bone marrow involvement affect prognosis in small-cell lung cancer?

Pasini F, Cetto GL, Pelosi G.

Ann Oncol. 1998 Mar;9(3):247-50. Review. No abstract available.

PMID:
9602256
40.

Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer.

Pasini F, Pelosi G, Verlato G, Guidi G, Pavanel F, Tummarello D, Masotti A, Cetto GL.

Ann Oncol. 1998 Feb;9(2):181-5.

PMID:
9553663
41.

Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods.

Molino A, Micciolo R, Turazza M, Bonetti F, Piubello Q, Corgnati A, Sperotto L, Recaldin E, Spagnolli P, Manfrin E, Bonetti A, Nortilli R, Tomezzoli A, Pollini GP, Modena S, Cetto GL.

Breast Cancer Res Treat. 1997 Sep;45(3):241-9.

PMID:
9386868
42.

Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis.

Molino A, Micciolo R, Turazza M, Bonetti F, Piubello Q, Bonetti A, Nortilli R, Pelosi G, Cetto GL.

Int J Cancer. 1997 Aug 22;74(4):433-7.

43.

Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN).

Pasini F, Cetto GL, Todeschini G, Di Marco A, Verlato G, Scognamiglio F, Meneghini V, Corato A, Ambrosetti A.

Anticancer Res. 1997 Jul-Aug;17(4A):2837-42.

PMID:
9252726
44.

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis.

Molino A, Pelosi G, Turazza M, Sperotto L, Bonetti A, Nortilli R, Fattovich G, Alaimo C, Piubello Q, Pavanel F, Micciolo R, Cetto GL.

Breast Cancer Res Treat. 1997 Jan;42(1):23-30.

PMID:
9116315
45.

Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.

Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.

Clin Cancer Res. 1996 Nov;2(11):1829-35.

46.

Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.

Perey L, Rosti G, Lange A, Pampallona S, Bosquée L, Pasini F, Humblet Y, Hamdan O, Cetto GL, Marangolo M, Leyvraz S.

Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S40-3. No abstract available.

PMID:
8899170
47.

Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma.

Bonetti A, Zaninelli M, Rodella S, Molino A, Sperotto L, Piubello Q, Bonetti F, Nortilli R, Turazza M, Cetto GL.

Breast Cancer Res Treat. 1996;38(3):289-97.

PMID:
8739082
48.

Extragonadal germ cell tumor: a clinical study.

Bassetto MA, Pasini F, Franceschi T, Mustacchi G, Cetto GL.

Anticancer Res. 1995 Nov-Dec;15(6B):2751-4. Review.

PMID:
8669858
49.

Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors.

Bonetti A, Franceschi T, Apostoli P, Messori A, Sperotto L, Cetto GL, Molino A, Leone R.

Ther Drug Monit. 1995 Feb;17(1):25-32.

PMID:
7725373
50.

Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations.

Pasini F, Pelosi G, Mostacci R, Santo A, Masotti A, Spagnolli P, Recaldin E, Cetto GL.

Ann Oncol. 1995 Jan;6(1):86-8.

PMID:
7536032

Supplemental Content

Loading ...
Support Center